Trials / Sponsors / SAb Biotherapeutics, Inc.
SAb Biotherapeutics, Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes Type 1 Diabetes | Phase 2 | 2025-11-25 |
| Active Not Recruiting | A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo PHA1A | Phase 1 | 2024-04-22 |
| Completed | Study of SAB-176 in Healthy Adult Participants Influenza A H1N1 | Phase 2 | 2021-06-23 |
| Unknown | Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 COVID-19, SARS-CoV2 | Phase 1 | 2020-08-20 |
| Completed | Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants Influenza Type A, Influenza Type B, Influenza | Phase 1 | 2020-07-29 |
| Completed | Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants COVID-19, SARS-CoV2 | Phase 1 | 2020-07-01 |